Rigel Pharmaceuticals RIGL Interest coverage
Interest coverage at other companies
Other financials
Where this comes from
Calculated from Rigel Pharmaceuticals’s reported figures.
Based on trailing twelve months.
The official record: Rigel Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Rigel Pharmaceuticals's interest coverage.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Rigel Pharmaceuticals's interest coverage?
- Rigel Pharmaceuticals (RIGL) reported interest coverage of 18.1× in Q1 2026.
- How has Rigel Pharmaceuticals's interest coverage changed year-over-year?
- Rigel Pharmaceuticals's interest coverage increased by 224.6% year-over-year, from 5.6× to 18.1×.
- What is the long-term trend for Rigel Pharmaceuticals's interest coverage?
- Over 5 years (2020 to 2025), Rigel Pharmaceuticals's interest coverage has grown at a -4.4% compound annual growth rate (CAGR), from -21.4× to 17.1×.
- What does interest coverage mean?
- Trailing-twelve-month operating income (EBIT) divided by interest expense. Measures how many times over the company can cover its interest payments from operating profit.